Efficacy and Safety of Daptomycin (With or Without Rifampin) in the Treatment of Staphylococcal Hip, Knee and Shoulder Prosthetic Joint Infection.

Trial Profile

Efficacy and Safety of Daptomycin (With or Without Rifampin) in the Treatment of Staphylococcal Hip, Knee and Shoulder Prosthetic Joint Infection.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Daptomycin; Rifampicin
  • Indications Bone and joint infections; Methicillin-resistant Staphylococcus aureus infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Acronyms Dapto-Studie
  • Most Recent Events

    • 25 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Planned End Date changed from 1 Jun 2011 to 1 Jun 2016 as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Planned initiation date changed from 1 Sep 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top